Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.

Two patients present with rash eruptions on different parts of the body. Can you correctly identify each case?

Winter rashes and allergies increase as cold, dry air strips skin moisture and weakens its barrier. Indoor living raises ...

The global psoriasis treatment market, valued at $27 billion in 2024, is projected to nearly double to $58 billion by 2032, according to research firm Fortune Business Insights. Psoriasis is a chronic ...

Dec 18 (Reuters) - Japan's Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two ...

Soligenix, Inc. (NASDAQ: SNGX) on Wednesday announced extended results of its ongoing Phase 2a trial of SGX302 (synthetic hypericin) for mild-to-moderate psoriasis. In this extension (Cohort 3) of the ...

A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular mechanism that contributes to the development of psoriasis—and at the same ...

A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular mechanism that contributes to the development of psoriasis - and at the same ...

The global psoriasis burden showed a slight increase from 1990 to 2021, with age-standardized incidence rates (ASIRs) increasing by 10.3% among men and 7.3% among women, and is projected to increase ...

A family riven by divorce or separation could triple the risk of a child developing psoriasis later in life, a new study says. The severe stress caused by such family upheaval might tax a child's ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for Tremfya (guselkumab) to children with plaque psoriasis or active psoriatic ...

People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says. Psoriasis patients taking GLP-1 drugs had a 78% lower risk of ...